Enstilar is a dual-action investigational aerosol foam containing calcipotriol, a vitamin D analog, and betamethasone dipropionate, a corticosteroid.

Enstilar is specifically indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older.

Enstilar is supplied as a foam for topical administration.

Submit your review
1
2
3
4
5
Submit
     
Cancel

Create your own review

Average rating:  
 0 reviews
  • Enstilar
  • Adverse effects associated with the use of Enstilar may include, but are not limited to, the following:

    application site irritation
    application site pruritus
    folliculitis
    skin hypopigmentation
    hypercalcemia
    urticaria
    exacerabation of psoriasis
  • It should be applied to affected areas once daily for up to 4 weeks, and rubbed in gently. Discontinue use when control is achieved. No more than 60 g every 4 days should be used.